BA
Bandhan Large Cap Fund Direct Growth
Latest NAV
-2.46% 1Y
Sign In to Add to Portfolio
Benchmark: BSE 100 TRI
Expense ratio
1.08%
AUM
₹2,180 Cr
Min SIP
₹100
Min lump sum
₹1,000
1Y
-2.46%
3Y (ann.)
+11.48%
5Y (ann.)
+9.72%
Launched
Jan 2013
Where the NAV sits & how risky it is
₹86.69
52-week range
at 47%
₹86.69
Low 31 Mar 2026₹80.40
High 02 Jan 2026₹93.80
Risk level
Very High
Low
Very high
NAV history
03 Jan 2013
Since inception
05 Oct 2026
Returns by period
1W
-2.77%
1M
-6.28%
3M
-3.64%
6M
+5.28%
1Y
-2.46%
3Y
+11.48%
5Y
+9.72%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 99.57%
Cash & other 0.43%
Sector split
Country split
Top 5 hold 30.0%
Top 10 hold 45.8%
75 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
8.40%
|
-0.64% |
| 2 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
7.36%
|
-20.81% |
| 3 | Reliance Industries
INE002A01018 |
Energy Oil & Gas Refining & Marketing |
India |
5.88%
|
-15.00% |
| 4 | Infosys
INE009A01021 |
Technology Information Technology Services |
India |
4.19%
|
-27.66% |
| 5 | NTPC
INE733E01010 |
Utilities Utilities - Regulated Electric |
India |
4.18%
|
+8.72% |
| 6 | State Bank of India
INE062A01020 |
Financial Services Banks - Regional |
India |
3.71%
|
+5.14% |
| 7 | Larsen & Toubro
INE018A01030 |
Industrials Engineering & Construction |
India |
3.33%
|
+3.45% |
| 8 | Bharti Airtel
INE397D01024 |
Communication Services Telecom Services |
India |
3.01%
|
-12.00% |
| 9 | Mahindra & Mahindra
INE101A01026 |
Consumer Cyclical Auto Manufacturers |
India |
2.95%
|
-15.40% |
| 10 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.83%
|
+5.35% |
About this scheme
The investment objective of the Scheme is to seek to generate capital growth from predominantly investing in large cap stocks.
Fund manager(s): Manish Gunwani, Prateek Poddar, Ritika Behera, Gaurav Satra
Exit load: Exit load of 0.5%, if redeemed within 30 days.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Jan 2013
Lump-sum min
₹1,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 124.0 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 35.8 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 33.1 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 33.1 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 31.7 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 31.6 pts ahead of this fund